Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study

J Hobart; T Ziemssen; P Feys; M Linnebank; A Goodman; R Farrell; R Hupperts; V Englishby; M McNeill; I Chang; G Lima

doi:10.1111/ene.13367

Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study

J Hobart, T Ziemssen, P Feys, M Linnebank, A Goodman, R Farrell, R Hupperts, V Englishby, M McNeill, I Chang, G Lima

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1111/ene.13367
Publication status	Published - Jun 2017

Access to Document

10.1111/ene.13367

Cite this

@conference{1ea8dcbe62dd4059b53545e7a0f5c05c,

title = "Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study",

author = "J Hobart and T Ziemssen and P Feys and M Linnebank and A Goodman and R Farrell and R Hupperts and V Englishby and M McNeill and I Chang and G Lima",

year = "2017",

month = jun,

doi = "10.1111/ene.13367",

language = "English",

}

TY - CONF

T1 - Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study

AU - Hobart, J

AU - Ziemssen, T

AU - Feys, P

AU - Linnebank, M

AU - Goodman, A

AU - Farrell, R

AU - Hupperts, R

AU - Englishby, V

AU - McNeill, M

AU - Chang, I

AU - Lima, G

PY - 2017/6

Y1 - 2017/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000405530100729&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

U2 - 10.1111/ene.13367

DO - 10.1111/ene.13367

M3 - Conference paper (not formally published)

ER -

Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE study

Access to Document

Other files and links

Cite this